Clomiphene Citrate Oral
Clomiplex 50 mg contains clomiphene citrate, a nonsteroidal selective estrogen receptor modulator (SERM) that binds estrogen receptors in the hypothalamus and pituitary, blocking estrogen's negative feedback and increasing gonadotropin-releasing hormone (GnRH) secretion. This leads to elevated LH and FSH, stimulating ovarian follicular development and ovulation in women with ovulatory dysfunction.
Clomiphene citrate is FDA-approved for the treatment of ovulatory dysfunction in women desiring pregnancy, with a standard starting dose of 50 mg daily for 5 days, beginning on or about day 5 of the menstrual cycle. The FDA label explicitly states that there are **no adequate or well-controlled studies demonstrating effectiveness in male infertility**, and that testicular tumors and gynecomastia have been reported in males using clomiphene.
In non-medical bodybuilding contexts, clomiphene is commonly referenced for post-cycle therapy (PCT) to restore endogenous testosterone production after anabolic-androgenic steroid use. A 2025 study in recreational bodybuilders evaluated clomiphene citrate monotherapy (25 mg/day) and found it effective for hormonal normalization. A 2025 systematic review and meta-analysis confirmed that SERM therapy significantly improves total testosterone, LH, and FSH in hypogonadal men. However, such use falls outside approved indications.
Research Properties of Clomiplex 50 mg
- Selective estrogen receptor modulator (SERM)
- FDA-approved for ovulation induction in ovulatory dysfunction
- Increases LH and FSH via hypothalamic-pituitary estrogen receptor blockade
- Investigated for post-cycle therapy in recreational bodybuilders
- 50 mg per tablet for research applications
Selective Estrogen Receptor Modulator
Clomiphene citrate is a nonsteroidal triphenylethylene derivative that acts as a mixed estrogen agonist/antagonist. It consists of a racemic mixture of zuclomiphene (cis) and enclomiphene (trans) isomers, with zuclomiphene having greater estrogenic activity and enclomiphene being primarily antiestrogenic.
The pharmacokinetic profile includes a half-life of approximately 5–7 days for the zuclomiphene isomer and shorter for enclomiphene. The drug undergoes hepatic metabolism and is excreted primarily in feces via bile, with enterohepatic recirculation. Peak plasma concentrations are achieved within 6 hours of oral administration.
For ovulation induction, the standard regimen is 50 mg daily for 5 days starting on day 5 of the cycle. If ovulation does not occur, the dose may be increased to 100 mg daily for 5 days in subsequent cycles. The maximum recommended dose is 100 mg daily, and therapy should not exceed six cycles.
Defining Characteristic
Hypothalamic-Pituitary Estrogen Receptor Blockade
Clomiphene's defining pharmacological characteristic is its ability to block estrogen feedback at the hypothalamus and pituitary, increasing GnRH and gonadotropin secretion, which drives follicular development and ovulation.
Clomiplex 50 mg vs Other Axiolabs Preparations
Axiolabs offers several ancillary compounds referenced in bodybuilding research. Tamoxiplex (tamoxifen) is another SERM commonly referenced for PCT, with a different tissue selectivity profile. Arimiplex (anastrozole) is an aromatase inhibitor that reduces estrogen synthesis rather than blocking receptors. Exeplex (exemestane) is a steroidal aromatase inhibitor. Clomiplex provides SERM activity via receptor blockade, distinct from aromatase inhibitors' mechanism.
Typical Dosage Ranges
In medically supervised ovulation induction, the standard clomiphene citrate dose is 50 mg once daily for 5 days, starting on or about day 5 of the menstrual cycle. If ovulation does not occur, subsequent cycles may use 100 mg daily for 5 days. Therapy should not exceed six cycles. In non-medical bodybuilding contexts, clomiphene is referenced for PCT at 25–50 mg daily for 4 weeks, but this use is not FDA-approved.
| Use Case |
Common Reference Range |
Frequency |
| Medical (ovulation induction) |
50 mg |
Once daily for 5 days, day 5–9 of cycle |
| Medical (dose escalation) |
100 mg |
Once daily for 5 days, if no ovulation at 50 mg |
| Non-medical (PCT, not approved) |
25–50 mg |
Once daily for 4 weeks |
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, clomiphene is commonly referenced for post-cycle therapy (PCT) after anabolic-androgenic steroid use. A 2025 study in recreational bodybuilders evaluated clomiphene citrate monotherapy (25 mg/day) and clomiphene combined with hCG, finding both effective for hormonal recovery. The addition of hCG was associated with superior recovery of semen parameters and testicular volume. However, no controlled studies support clomiphene use in combination with other Tamoxiplex or Arimiplex for PCT.
Managing Side Effects
Common adverse effects of clomiphene citrate include ovarian enlargement (13.6%), vasomotor flushes (10.4%), abdominal-pelvic discomfort/bloating (5.5%), nausea and vomiting (2.2%), and breast discomfort (2.1%). Visual symptoms such as blurred vision, floaters, and photophobia occur in approximately 1.5% of patients and increase in incidence with higher total dose or longer duration of therapy. Patients should be advised that these visual symptoms may make driving or operating machinery hazardous.
Important
Individual Response Varies
The information above is for educational reference and does not constitute medical advice. Clomiphene citrate is not approved for male use or performance enhancement.
Important Safety Information
Clomiphene citrate is contraindicated in pregnancy (Pregnancy Category X), in patients with liver disease or history of liver dysfunction, in patients with abnormal uterine bleeding of undetermined origin, and in patients with ovarian cysts or enlargement not due to polycystic ovarian syndrome. Visual symptoms occur in approximately 1.5% of patients and may be irreversible, especially with increased dosage or duration of therapy.
Important
Non-Medical Use
Non-medical use of clomiphene citrate falls outside approved indications. The FDA label explicitly states that there are no adequate studies demonstrating effectiveness in male infertility, and testicular tumors and gynecomastia have been reported in males using clomiphene.
Potential Adverse Effects
Common adverse reactions include ovarian enlargement (13.6%), vasomotor flushes (10.4%), abdominal-pelvic discomfort (5.5%), nausea/vomiting (2.2%), breast discomfort (2.1%), visual symptoms (1.5%), and headache (1.3%). Postmarketing reports include arrhythmia, chest pain, hypertension, pulmonary embolism, seizure, stroke, hepatitis, and pancreatitis. Prolonged use may increase the risk of borderline or invasive ovarian tumors.
Conditions Requiring Medical Evaluation
Clomiphene citrate should not be used in patients with liver disease, abnormal uterine bleeding of undetermined origin, or ovarian cysts not due to PCOS. Caution is advised in patients with uterine fibroids due to potential for further enlargement. Pelvic examination is necessary prior to the first and each subsequent course of treatment.
Monitoring Considerations
During clomiphene citrate therapy, monitoring may include pelvic examination, ovarian size assessment, and evaluation for visual symptoms. In male users, monitoring of testosterone, LH, and FSH may be considered, though no standardized protocol exists for non-approved use.
Product Care
Storage & Handling
Store tablets in a closed container at controlled room temperature, away from excessive heat, moisture, and direct light. Keep out of reach of children. Do not use if the packaging is damaged or if tablets appear discolored.
Further Safety Information
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with no external product details. Products are supplied through the official Axiolabs distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is available
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Clomiplex 50 mg product, use the security code on the packaging and cross-check it on the official Axiolabs site. A credible certificate of analysis should show HPLC purity above 95 percent and mass spectrometry confirmation of the correct molecular weight (598.0 g/mol for clomiphene citrate). Original packaging and batch documentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Recommended Conditions
Store tablets in a closed container at controlled room temperature (15–25°C), away from excessive heat, moisture, and direct light. Keep the product in its original packaging until use.
Do not use if the packaging is damaged or if tablets appear discolored or degraded. Keep out of reach of children.
Quick Reference
Do & Don't
- Do store at 15–25°C
- Do keep in original packaging
- Do protect from moisture and light
- Don't expose to excessive heat
- Don't use if tablets appear discolored
- Don't store in bathroom or humid areas
What is Clomiplex 50 mg used for?
Clomiplex 50 mg contains clomiphene citrate, a selective estrogen receptor modulator. In medical practice, it is FDA-approved for ovulation induction in women with ovulatory dysfunction. In non-medical bodybuilding contexts, it is referenced for post-cycle therapy, though this use is not approved.
How often should Clomiplex 50 mg be taken?
The FDA-approved dose is 50 mg once daily for 5 days, starting on or about day 5 of the menstrual cycle. Non-medical PCT protocols reference 25–50 mg daily for 4 weeks, but these are not standardized or approved.
Does Clomiplex 50 mg require PCT?
Clomiphene citrate is itself commonly used as a PCT agent in non-medical contexts to restore endogenous testosterone production after anabolic steroid cycles. It is not an anabolic steroid and does not suppress testosterone production.
What does clomiphene citrate do?
Clomiphene citrate blocks estrogen receptors in the hypothalamus and pituitary, reducing estrogen's negative feedback and increasing GnRH, LH, and FSH secretion. This stimulates follicular development and ovulation in women with ovulatory dysfunction.
How long does clomiphene citrate take to work?
Ovulation most often occurs 5 to 10 days after a course of clomiphene citrate. For PCT, a 2025 study found that clomiphene citrate at 25 mg/day facilitated earlier hormonal normalization compared to no treatment.
Is clomiphene the best SERM for PCT?
No single SERM is universally superior. Clomiphene and Tamoxiplex (tamoxifen) are both commonly referenced for PCT. A 2025 systematic review confirmed that SERM therapy significantly improves testosterone, LH, and FSH in hypogonadal men.
What is the difference between Clomiplex and Tamoxiplex?
Clomiplex (clomiphene citrate) and Tamoxiplex (tamoxifen) are both SERMs but have different tissue selectivity profiles. Clomiphene is FDA-approved for ovulation induction, while tamoxifen is approved for breast cancer treatment.
What is the difference between Clomiplex and Arimiplex?
Clomiplex (clomiphene) is a SERM that blocks estrogen receptors. Arimiplex (anastrozole) is an aromatase inhibitor that reduces estrogen synthesis. These represent different mechanisms of estrogen management.
Is 50 mg of clomiphene a lot?
50 mg is the standard FDA-approved starting dose for ovulation induction. The dose may be increased to 100 mg daily if ovulation does not occur. Therapy should not exceed six cycles.
What strength is Clomiplex 50 mg?
Clomiplex 50 mg by Axiolabs contains 50 mg of clomiphene citrate per tablet. It is supplied in packages of 50 or 100 tablets. This is a research presentation.
What are the risks of clomiphene in men?
The FDA label states that there are no adequate studies demonstrating effectiveness in male infertility, and testicular tumors and gynecomastia have been reported in males using clomiphene. The cause and effect relationship is not known, but this warrants caution.
What are the visual side effects of clomiphene?
Visual symptoms such as blurred vision, floaters, photophobia, and scotomata occur in approximately 1.5% of patients. These symptoms increase with higher doses or longer duration and may be irreversible. Patients should be warned that driving or operating machinery may be hazardous.
No reviews found
Please log in to write Clomiplex 50 mg review.
